Arkolith/Insider Trading/EKSO/Form 4

Wallen Rhonda A.

DirectorEKSO BIONICS HOLDINGS, INC. (EKSO) · full profile →Form 4 · filed Jun 17, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 9, 2022Grant(A)52K—$075K
Jun 10, 2021Grant(A)18K—$023K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001838009-22-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML